Holen Sie sich die Stockscreener-App
7.29
3.71%
0.26
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AUPH?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$7.03
Offen:
$7.1
24-Stunden-Volumen:
818.91K
Relative Volume:
0.59
Marktkapitalisierung:
$1.01B
Einnahmen:
$175.51M
Nettoeinkommen (Verlust:
$-78.02M
KGV:
-13.75
EPS:
-0.53
Netto-Cashflow:
$-34.18M
1W Leistung:
+6.12%
1M Leistung:
+16.46%
6M Leistung:
+41.02%
1J Leistung:
-17.53%
1-Tages-Spanne:
$7.01
$7.36
1-Wochen-Bereich:
$6.42
$7.36
52-Wochen-Spanne:
$4.71
$10.05
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
Firmenname
Aurinia Pharmaceuticals Inc
Sektor
Branche
Telefon
250-744-2487
Adresse
#140, 14315 - 118 AVENUE, EDMONTON, BC
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-05-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-10-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-01-25 | Bestätigt | H.C. Wainwright | Buy |
| 2020-11-03 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-17 | Eingeleitet | BTIG Research | Buy |
| 2020-05-05 | Eingeleitet | Cowen | Outperform |
| 2020-01-10 | Eingeleitet | Jefferies | Buy |
| 2019-12-16 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-16 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-02-08 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-18 | Bestätigt | H.C. Wainwright | Buy |
| 2017-04-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-22 | Bestätigt | FBR & Co. | Outperform |
| 2016-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-17 | Bestätigt | H.C. Wainwright | Buy |
| 2016-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-05-08 | Eingeleitet | MLV & Co | Buy |
Alle ansehen
Aurinia Pharmaceuticals Inc Aktie (AUPH) Neueste Nachrichten
Bank of New York Mellon Corp Purchases 77,510 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat
Jupiter Asset Management Ltd. Sells 88,555 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Gap Up to $6.58 - MarketBeat
How the (AUPH) price action is used to our Advantage - Stock Traders Daily
Aurinia Pharmaceuticals reshuffles board, adds new director By Investing.com - Investing.com Australia
Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference - Business Wire
Aurinia Pharmaceuticals (AUPH) Stock Gains After Hours Following Board Realignment - Stocks Telegraph
Aurinia Pharmaceuticals reshuffles board, adds new director - Investing.com
Aurinia Pharmaceuticals Announces Board Restructuring and Director Changes - TipRanks
Aurinia Pharmaceuticals reshuffles board, adds new director - Investing.com India
Aurinia Announces Board Restructuring - Business Wire
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Down 3.2% - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 3.3% - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Aurinia Pharmaceuticals (NASDAQ:AUPH) - MarketBeat
H.C. Wainwright reiterates Buy rating on Aurinia Pharma shares - Investing.com
Aurinia doses first subject in Phase Ia trial of AUR200 for autoimmune diseases - Clinical Trials Arena
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Surges 30% Yet Its Low P/S Is No Reason For Excitement - Simply Wall St
Traders Purchase High Volume of Aurinia Pharmaceuticals Call Options (NASDAQ:AUPH) - MarketBeat
Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial - sharewise
Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial - Business Wire
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference - Manchestertimes
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 13.8% in August - MarketBeat
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference - sharewise
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 2.4% - MarketBeat
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference - Marketscreener.com
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Passes Above 50-Day Moving Average of $5.73 - MarketBeat
Do Options Traders Know Something About Aurinia (AUPH) Stock We Don't? - MSN
Do Options Traders Know Something About Aurinia (AUPH) Stock We Don't? - Yahoo Finance
Aurinia Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:AUPH) - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 5.4% - Defense World
(AUPH) Technical Pivots with Risk Controls - Stock Traders Daily
Price T Rowe Associates Inc. MD Increases Stock Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Up 13.1% in July - MarketBeat
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock Position Raised by Vanguard Group Inc. - Defense World
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Up 5.4% - MarketBeat
Cetera Advisors LLC Has $301,000 Stock Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
California State Teachers Retirement System Trims Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals faces boardroom shakeup demand By Investing.com - Investing.com Australia
Aurinia Pharmaceuticals faces boardroom shakeup demand - Investing.com
This Insider Has Just Sold Shares In Aurinia Pharmaceuticals - Simply Wall St
AUPHAurinia Pharmaceuticals Inc. Latest Stock News & Market Updates - StockTitan
The growth track for Aurinia Pharmaceuticals Inc (AUPH) has changed recently - SETE News
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Sold by DekaBank Deutsche Girozentrale - Defense World
Scott Michael Habig Sells 18,249 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock - Defense World
Scott Michael Habig Sells 18,249 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock - MarketBeat
Investor’s Delight: Aurinia Pharmaceuticals Inc (AUPH) Closes Weak at 5.32, Down -5.34 - The Dwinnex
Virtu Financial LLC Takes Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Long Term Trading Analysis for (AUPH) - Stock Traders Daily
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) to Post Q1 2025 Earnings of $0.05 Per Share, Leerink Partnrs Forecasts - MarketBeat
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Forecasted to Post Q1 2025 Earnings of $0.05 Per Share - Defense World
Finanzdaten der Aurinia Pharmaceuticals Inc-Aktie (AUPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aurinia Pharmaceuticals Inc-Aktie (AUPH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Balakrishnan Brinda | Director |
May 21 '24 |
Sale |
5.74 |
520 |
2,985 |
17,523 |
| Billen Daniel | Director |
May 21 '24 |
Sale |
5.74 |
5,252 |
30,146 |
28,141 |
| Jayne David R.W. | Director |
May 21 '24 |
Sale |
5.74 |
4,946 |
28,390 |
44,364 |
| Leversage Jill | Director |
May 21 '24 |
Sale |
5.74 |
5,610 |
32,201 |
12,918 |
| MacKay-Dunn R. Hector | Director |
May 21 '24 |
Sale |
5.74 |
5,630 |
32,316 |
18,595 |
| Greenleaf Peter | Chief Executive Officer |
Mar 06 '24 |
Sale |
5.60 |
126,981 |
711,094 |
1,522,114 |
| Miller Joseph M | Chief Financial Officer |
Mar 06 '24 |
Sale |
5.60 |
34,811 |
194,942 |
495,928 |
| Donley Matthew Maxwell | EVP, Ops & Strategy |
Mar 06 '24 |
Sale |
5.51 |
40,665 |
224,064 |
584,072 |
| Habig Scott Michael | Chief Commercial Officer |
Mar 06 '24 |
Sale |
5.60 |
17,777 |
99,551 |
474,587 |
| Robertson Stephen P. | EVP, General Counsel |
Mar 06 '24 |
Sale |
5.60 |
57,745 |
323,372 |
443,824 |
1.26%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):